CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 83  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0594
LYS 10.0332
GLU 20.0360
LEU 30.0290
ARG 40.0168
CYS 50.0137
GLN 60.0150
CYS 70.0308
ILE 80.0116
LYS 90.0211
THR 100.0068
TYR 110.0164
SER 120.0084
LYS 130.0389
PRO 140.0271
PHE 150.0113
HIS 160.0029
PRO 170.0179
LYS 180.0176
PHE 190.0072
ILE 200.0065
LYS 210.0132
GLU 220.0078
LEU 230.0123
ARG 240.0165
VAL 250.0170
ILE 260.0080
GLU 270.0128
SER 280.0127
GLY 290.0111
PRO 300.0044
HIS 310.0141
CYS 320.0100
ALA 330.0104
ASN 340.0165
THR 350.0070
GLU 360.0104
ILE 370.0083
ILE 380.0083
VAL 390.0109
LYS 400.0125
LEU 410.0151
SER 420.0251
ASP 430.0114
GLY 440.0132
ARG 450.0230
GLU 460.0248
LEU 470.0195
CYS 480.0066
LEU 490.0058
ASP 500.0029
PRO 510.0048
LYS 520.0259
GLU 530.0123
ASN 540.0185
TRP 550.0108
VAL 560.0154
GLN 570.0301
ARG 580.0405
VAL 590.0169
VAL 600.0274
GLU 610.0296
LYS 620.0214
PHE 630.0205
LEU 640.0278
LYS 650.0342
ARG 660.0271
ALA 670.0429
GLU 680.0594
ASN 690.0439

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.